Eswatini is burdened with a high HIV and TB infection rate, while this is ongoing, it is also important to think of solutions to manage COVID-19. In an interview, Dr Bernhard Kerschberger, MSF Head of Mission in Eswatini, explains how our teams are achieving this.
For the first time in a decade, international and domestic funds available to fight HIV and TB declined in 2018, putting further pressure on countries facing these epidemics.
MSF is handing over its medical activities to the Eswatini (Eswatini) Ministry of Health and local service partners after 8 years of service in the Manzini Region.
Sellah Moraa, Project Coordinator from the Manzini project in Eswatini, shares how MSF goes ‘above & beyond’ to ensure patients with TB receive world class treatment
How MSF is pushing to get a game-changing new medicine for drug-resistant TB registered in South Africa before it’s too late for thousands.
Every year, on average 7000 people in Eswatini are diagnosed with Tuberculosis (TB), of which around 900 will develop Drug Resistant TB (DR-TB).
Winile from Eswatini was diagnosed with Multi-Drug Resistant TB (MD-RTB) and started treatment in March 2013.
Tholakele, 39, has drug-resistant tuberculosis (DR-TB) and started treatment in May 2016 at the MSF supported Moneni National TB Hospital in central Eswatini.